BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 20478511)

  • 21. Novel quadrivalent meningococcal A, C, W-135 and Y glycoconjugate vaccine for the broader protection of adolescents and adults.
    Pace D
    Future Microbiol; 2010 Nov; 5(11):1629-40. PubMed ID: 21133685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Meningitis Vaccine Project.
    LaForce FM; Konde K; Viviani S; Préziosi MP
    Vaccine; 2007 Sep; 25 Suppl 1():A97-100. PubMed ID: 17521780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meningococcal disease and travel.
    Wilder-Smith A; Memish Z
    Int J Antimicrob Agents; 2003 Feb; 21(2):102-6. PubMed ID: 12615371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meningococcal disease: the advances and challenges of meningococcal disease prevention.
    Yogev R; Tan T
    Hum Vaccin; 2011 Aug; 7(8):828-37. PubMed ID: 21832882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The changing and dynamic epidemiology of meningococcal disease.
    Halperin SA; Bettinger JA; Greenwood B; Harrison LH; Jelfs J; Ladhani SN; McIntyre P; Ramsay ME; Sáfadi MA
    Vaccine; 2012 May; 30 Suppl 2():B26-36. PubMed ID: 22178525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Meningococcal disease in the Netherlands: media hype, but not an epidemic].
    van Furth AM; Zaaijer HL
    Ned Tijdschr Geneeskd; 2001 Sep; 145(36):1716-8. PubMed ID: 11572168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meningococcal disease: a review on available vaccines and vaccines in development.
    Bröker M; Fantoni S
    Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quadrivalent meningococcal vaccines: hyporesponsiveness as an important consideration when choosing between the use of conjugate vaccine or polysaccharide vaccine.
    Bröker M; Veitch K
    Travel Med Infect Dis; 2010 Jan; 8(1):47-50. PubMed ID: 20188306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contributions of the Norwegian Institute of Public Health to the development of vaccines against serogroup B meningococcal disease.
    Rosenqvist E; Holst J; Nøkleby H
    Vaccine; 2007 Jan; 25(6):965-6. PubMed ID: 17052822
    [No Abstract]   [Full Text] [Related]  

  • 30. Meningococcal disease and prevention at the Hajj.
    Borrow R
    Travel Med Infect Dis; 2009 Jul; 7(4):219-25. PubMed ID: 19717104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Changing Epidemiology of Meningococcal Disease.
    Cohn A; MacNeil J
    Infect Dis Clin North Am; 2015 Dec; 29(4):667-77. PubMed ID: 26610420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Meningococcal vaccination: which one? When? Why?].
    Rosenheim M
    Rev Prat; 2004 Mar; 54(5):512-8. PubMed ID: 15176510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Global spread of meningococcal serogroup W135].
    Vestergård D; David KP
    Ugeskr Laeger; 2008 Sep; 170(39):3044-7. PubMed ID: 18822228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infectious disease. An ill wind, bringing meningitis.
    Roberts L
    Science; 2008 Jun; 320(5884):1710-5. PubMed ID: 18583588
    [No Abstract]   [Full Text] [Related]  

  • 35. Epidemiology and meningococcal serogroup distribution in the United States.
    Hershey JH; Hitchcock W
    Clin Pediatr (Phila); 2010 Jun; 49(6):519-24. PubMed ID: 20507868
    [No Abstract]   [Full Text] [Related]  

  • 36. Meningococcal meningitis.
    Aguado T; Bertherat E; Djingarey M; Kandolo D; Kieny MP; Kondé K; LaForce FM; Nelson CB; Perea W; Préziosi MP
    Nat Rev Microbiol; 2005 Jan; 3(1):10-1. PubMed ID: 15635779
    [No Abstract]   [Full Text] [Related]  

  • 37. Travelling to South Africa for the 2010 FIFA world cup.
    Leggat PA; Shaw MT; Toovey S
    Travel Med Infect Dis; 2010 Mar; 8(2):74-8. PubMed ID: 20478512
    [No Abstract]   [Full Text] [Related]  

  • 38. [Group B meningococcal invasive infections: an unresolved public health problem].
    Crisinel PA; Posfay-Barbe KM
    Rev Med Suisse; 2011 Feb; 7(283):447-50. PubMed ID: 21452513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies.
    Sáfadi MA; McIntosh ED
    Expert Rev Vaccines; 2011 Dec; 10(12):1717-30. PubMed ID: 22085175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Travelers' protection against meningococcal disease: a new vaccine option.
    Black S
    J Travel Med; 2010; 17 Suppl():18-25. PubMed ID: 20849429
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.